Overview

The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
Randomized, multi-center, double-blind, two-armed, parallel active groups, prospective trial to evaluate the efficacy and safety of local anesthetic Chloroprocaine at two different concentrations ( at 1% and 2%) in a pediatric population subjected to peripheral nerve block due to Inguinal hernia repair or Flat foot surgery. The present Protocol is part of an extensive Pediatric Investigational Plan (PIP) in the contest of the marketing authorization application of chloroprocaine use for perineural block. The PDCO has adopted a positive opinion.
Phase:
Phase 2
Details
Lead Sponsor:
Sintetica SA
Treatments:
Chloroprocaine
Pharmaceutical Solutions
Procaine